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Abstract
Background: It is still uncertain whether increased blood pressure (BP) has a stronger effect on the risk of 
cardiovascular disease (CVD) in lean persons than in obese persons. We tested it using a data set collected from a large 
cohort of Chinese adults.
Methods: Systolic and diastolic BP, body mass index (BMI) and other variables were measured in 169,871 Chinese men 
and women ≥ 40 years of age in 1991 using standard protocols. Follow-up evaluation was conducted in 1999-2000, 
with a response rate of 93.4%. Data were analyzed with Cox proportional hazards models.
Results: After adjusted for age, sex, cigarette smoking, alcohol consumption, high school education, physical inactivity, 
geographic region, and urbanization, we found that the effects of systolic or diastolic BP on risk of CVD generally 
increased with the increasing BMI levels (underweight, normal, overweight, and obese). For example, hazard ratios 
(HRs) and 95% confidence interval (CI) per 1- standard deviation (SD) increase in systolic BP within corresponding BMI 
levels were 1.27(1.21-1.33), 1.45(1.41-1.48), 1.52 (1.45-1.59) and 1.63 (1.51-1.76), respectively. Statistically significant 
interactions (P < 0.0001) were observed between systolic BP, diastolic BP and BMI in relation to CVD. In baseline 
hypertensive participants we found both obese men and women had higher risk of CVD than normal-weight persons. 
The multivariate-adjusted HRs(95%CI) were 1.23(1.03-1.47) and 1.20(1.02-1.40), respectively.
Conclusion: Our study suggests that the magnitude of the association between BP and CVD generally increase with 
increasing BMI. Hypertension should not be regarded as a less serious risk factor in obese than in lean or normal-
weight persons in Chinese adults.
Background
Cardiovascular disease (CVD) was the leading cause of
death in China in recent decades [1]. Prospective cohort
studies have documented a strong, linear, and indepen-
dent positive association between blood pressure (BP)
levels and risk of CVD incidence and mortality among
the general population [2-5]. Meanwhile, obesity has
already been shown to play an important role for CVD
[6]. As important risk factors of CVD, hypertension and
obesity both showed increasing trends among Chinese
population [7,8]. However, it is highly debatable on the
r ole of obesity as an effect modifier in the associa tion
between BP and CVD. Some studies have reported that
hypertension or elevated BP has a stronger effect on CVD
risk in lean than in obese persons [9-15], whereas others
either have reported no such relation or have even
reported some opposite results [16-19]. Most previous
studies were conducted in western populations in which
the mean body mass index (BMI) was relatively high by
comparison with China. In the present study, data from a
large population-based prospective cohort in China were
used to analyze the relationship of BP and BMI on risk of
CVD.
Methods
Study population
In the 1991 China National Hypertension Survey [20], a
multistage random cluster sampling design was used to
select a representative sample of the general Chinese
population aged 15 years and older from 30 provinces of
mainland China. Of the 30 provinces, 13 were not
included in the follow-up study because contact informa-
tion was not available for study subjects. The baseline
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characteristics of subjects from the remaining 17 prov-
inces that were included in this analysis were similar to
those in the 13 excluded provinces [21]. In 1999 and 2000,
from the 17 provinces, 169871 study subjects (83,533
men and 86,338 women) who were 40 years or older at
their baseline examination were eligible for participation
in the follow-up study. From them, a total of 158, 666
(93.4%) study participants (or their proxies) were identi-
fied and interviewed as part of the follow-up study. In this
report, study participants with missing BP values (n =
285), a history of CVD (n = 4,192) and missing BMI val-
ues (n = 14721) at the baseline examination were
excluded from related analyses, respectively.
Baseline examination
All baseline data were collected at a single clinic visit by
specially trained physicians and nurses using standard-
ized methods with stringent levels of quality control [20].
Data on demographic characteristics, medical history,
and lifestyle risk factors were obtained using a standard
questionnaire administered by trained staff. Work-related
physical activity was assessed because leisure-time physi-
cal activity was uncommon. Cigarette smokers were
defined as having smoked at least one cigarette per day
for 1 or more years. The amount and type of alcohol con-
sumed during the past year were collected. Three BP
measurements were taken after the study participant had
been seated quietly for 5 minutes using a standard mer-
cury sphygmomanometer according to a standard proto-
col [22]. The first and fifth Korotkoff sounds were
recorded as systolic and diastolic BP, respectively. Partici-
pants were instructed not to eat, drink alcohol, coffee, or
tea, smoke, or exercise for at least 30 minutes prior to
their BP measurement. The mean of 3 BP measures was
used in all analyses. Body weight and height were mea-
sured in light indoor clothing without shoes using a stan-
dard protocol. BMI was calculated as weight in kilograms
divided by height in square meters. According to the defi-
nition of obesity from Working Group on Obesity in
China (WGOC) [23], participants in the present study
were divided into 4 BMI levels including underweight
(<18.5 kg/m2), normal (18.5-23.9 kg/m2), overweight (24-
27.9 kg/m2), and obese (≥ 28 kg/m2). Baseline hyperten-
sive participants were defined as participants with sys-
tolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg, or
having taken antihypertensive medication in last two
weeks before baseline interview.
Follow-up data collection
The follow-up examination was conducted between 1999
and 2000, which included tracking study participants or
their proxies to a current address, performing in-depth
interviews with the participants or proxies to ascertain
disease status and vital information, and obtaining hospi-
tal records and death certificates. If a study participant
reported a hospitalization or emergency room overnight-
stay due to acute myocardial infarction or stroke during
the in-person interview, the participant's hospital
records, including medical history, physical examination
findings, laboratory test results, and discharge diagnosis,
were abstracted by trained staff using a standard form. In
addition, photocopies of selected sections of the partici-
pant's in-patient record, discharge summary, electrocar-
diogram, and pathology reports were obtained. All deaths
reported during the in-person interview were verified by
obtaining death certificates from the local public health
department or police department. If death occurred dur-
ing a hospitalization, the participant's hospital records
and autopsy results were also abstracted by trained staff
using a standard form. If death occurred outside of the
hospital, detailed information on medical history was
obtained from a family member or healthcare provider.
An end-point assessment committee within each prov-
ince reviewed all abstracted information to confirm or
reject the occurrence of study outcomes using pre-estab-
lished criteria. A study-wide end-point assessment com-
mittee at the Chinese Academy of Medical Sciences in
Beijing, China, reviewed all medical records and deter-
mined the final diagnosis of the event or the underlying
cause of death. Two committee members independently
verified the diagnosis and discrepancies were adjudicated
by discussion involving additional committee members.
All members of the local and study-wide end-point
assessment committees were blinded to the study partici-
pant's baseline risk factor information. Causes of death
were coded according to the International Classification
of Diseases, Ninth Revision (ICD-9).
For this analysis, the CVD group lists those with a con-
firmed diagnosis of acute myocardial infarction or stroke
during the follow-up period or mortality with a cardio-
vascular event (ICD-9 390.0-398.9, 401.0-429.9, and
430.0-438.9) listed as an underlying cause of death. The
coronary heart disease (CHD) group lists those with a
confirmed diagnosis of acute myocardial infarction dur-
ing the follow-up period or CHD listed as an underlying
cause of death (ICD-9 410.0-414.9). Finally, the stroke
group lists those with a confirmed diagnosis of stroke
during the follow-up period or stroke listed as an under-
lying cause of death (ICD-9 430.0-438.9).
This study was approved by the Cardiovascular Insti-
tute and Fu Wai Hospital Ethics Committee and the
Tulane University Health Sciences Center Institutional
Review Board. Written informed consent was obtained
from all study participants at their follow-up visit.
Statistical analysis
Previous study found that there was a linear and indepen-
dent relationship between systolic and diastolic BP andWang et al. BMC Public Health 2010, 10:189
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the risk of CVD in our cohort [5]. Thereafter, all analyses
were performed with systolic BP and diastolic BP on a
continuous scale. Data were analyzed with Cox propor-
tional hazards models. We analyzed the modifying effect
of BMI on the association between BP and CVD by com-
puting the HRs for a 1- standard deviation (SD) increase
in systolic BP and diastolic BP by fitting a separate model
for each of the BMI levels. In the present study, SD of sys-
tolic BP and diastolic BP were 22.1 mmHg and 12.0
mmHg, respectively.
We adjusted for baseline age, sex, cigarette smoking,
alcohol consumption, high school education, physical
inactivity, geographic region (south vs. north), and
urbanization (rural vs. urban) in the models. Interactions
between BP and BMI were then modeled by incorporat-
ing an interaction term between systolic BP or diastolic
BP and BMI.
All statistical models were performed with the SAS sta-
tistical software (version 9.1; SAS Institute, Cary, NC).
Results
Baseline characteristics of study participants according to
BMI levels are presented in Table 1. Those with higher
BMI levels were most likely to be younger, female, not
alcohol drinkers or cigarette smokers, living in urban or
north China, physically inactive, having high school edu-
cation and having higher systolic BP or diastolic BP at the
baseline examination. The obese and underweight partic-
ipants both had higher crude incidence of CVD than nor-
mal-weight persons.
Table 2 presents the results for the associations of BP
with incident CVD (fatal and nonfatal cases together) by
separate baseline BMI levels and for all levels combined.
Both systolic BP and diastolic BP were strongly associated
with CVD with statistical significance at each BMI level
and at all levels combined after adjusted for age, sex, ciga-
rette smoking, alcohol consumption, high school educa-
tion, physical inactivity, geographic region, and
urbanization. HRs and 95% CI per 1-SD increase in sys-
tolic BP and diastolic BP computed with Cox propor-
tional hazards models for all BMI levels combined were
1.42 (1.40-1.45), and 1.40 (1.37-1.43). HRs and 95%CI per
1-SD increase in systolic BP or diastolic BP both
increased among four BMI levels (underweight, normal,
overweight, and obese). The results indicated that the
effects of BP on risk of CVD generally increased with the
increasing BMI levels.
Statistical evidence was also found for interactions
between BMI and both systolic BP and diastolic BP in the
prediction of all CVD (both P < 0.0001). When partici-
pants were divided by sex (men vs. women), the interac-
tions between BMI and both systolic BP and diastolic BP
in the prediction of all CVD remained positive (both P <
0.001) (Table 3).
We examined the association between levels of BMI
and risk of CVD in baseline hypertensive participants
after adjusted multivariate factors by Cox proportional
hazards models (Figure 1). Compared with the reference
group (BMI between 18.5 and 23.9 kg/m2), among four
corresponding BMI levels men with BMI of 28 kg/m2 or
higher had the highest hazard ratio of CVD, 1.23(95% CI,
1.03-1.47). For women, participants with BMI of 28 kg/
m2 or higher also had the highest hazard ratio, 1.20(95%
CI, 1.02-1.40).
We also examined the association between levels of
BMI and risk of CVD in baseline non-hypertensive par-
ticipants (Figure 2). On the contrary, we found that both
men and women with BMI of 18.5 kg/m2 or lower had the
highest risk of CVD among four corresponding BMI lev-
els. Compared with the reference group (BMI between
18.5 and 23.9 kg/m2), the multivariate-adjusted
HRs(95%CI) were 1.36(1.22-1.52) and 1.43(1.25-1.63),
respectively.
We also examined the interactions between BP and
western BMI groupings including underweight (<18.5 kg/
m2), normal (18.5-24.9 kg/m2), overweight (25-29.9 kg/
m2), and obese (≥ 30 kg/m2) in our cohort study, and the
pattern and conclusion of results did not change.
Sensitivity Analysis
After excluding the incident CVD that occurred during
the first 3 years of follow-up, we still found that the
effects of BP on risk of CVD generally increased with the
increasing BMI levels. HRs and 95% CI per 1-SD increase
in systolic BP computed with Cox proportional hazards
models within four BMI levels (underweight, normal,
overweight, and obese) were 1.26(1.19-1.33), 1.44(1.40-
1.49), 1.51(1.43-1.58) and 1.61(1.47-1.76), respectively.
HRs and 95% CI per 1-SD increase in diastolic BP within
four BMI levels were 1.25(1.18-1.32), 1.40(1.36-1.45),
1.46(1.38-1.54) and 1.48(1.35-1.63), respectively. Statisti-
cal evidence was still found for interactions between BMI
and both systolic BP and diastolic BP in the prediction of
all CVD (both P < 0.001).
Discussion
In the present large prospective cohort of Chinese adults,
our study observed the significant interactions between
systolic BP or diastolic BP and BMI in relation to CVD
(both P < 0.0001) after other important risk factors were
adjusted, including age, sex, cigarette smoking, alcohol
consumption, high school education, physical inactivity,
geographic region and urbanization. Furthermore, we
found the interactions between systolic BP or diastolic BP
and BMI in relation to CVD remained positive when par-
ticipants were divided by men and women (both P <
0.001). These findings suggested that the associationWang et al. BMC Public Health 2010, 10:189
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between BP and CVD increased with increasing BMI in
Chinese population.
Findings of interaction analysis (table 2) suggested that
the effects of BP on risk of CVD generally increased with
the increasing BMI levels, for instance, HRs per 1-SD
increase in systolic BP within 4 BMI levels (underweight,
normal, overweight, obese) were 1.27, 1.45, 1.52 and 1.63,
respectively, which indicated that elevated BP would be
more harmful in obese persons for CVD risk. Therefore,
obese persons would have more benefits from lowering
the BP. Considering that hypertension has become the
leading preventable risk factor for CVD and all-cause
mortality in developing countries [24,25], our observa-
tion may have important implications for interpreting the
benefit of the treatment of hypertension.
Relationship of BP and BMI on the risk of CVD has not
a universal conclusion. High risk among lean hyperten-
sive persons has been reported for CVD risk [9-15] and
total mortality [26,27]. On the contrary some previous
studies [16-19] did not support the suggestion that lean
persons were more dangerous than obese persons on risk
of CVD. In the 26 year follow up and the 34 year follow
up in Framingham [17] it was reported that hypertension
is at least as dangerous in obese as in lean persons at all
ages in either sex. Stamler and coauthors [14] reported
that lean hypertensive persons had a higher risk not only
for death of CVD, but also for death due to cirrhosis,
nonmalignant respiratory disease, violence, and malig-
nant neoplasms than obese hypertensive persons. This
suggested that excess alcohol intake and smoking were
important factors that contributed to the excess risk.
However, in a recent study, Karri Silventoinen found that
the adjustment for socioeconomic factors had no effect
on the interactions between BP and BMI and meanwhile
observed a stronger effect of BP on CVD risk in obese as
opposed to lean or normal-weight men in a large cohort
of young Swedish men [19]. Our results confirmed the
findings from Karri Silventoinen with adjustment for
alcohol consumption, cigarette smoking and other
important risk factors of CVD. We found significant
interactions between systolic BP, diastolic BP and BMI in
relation to CVD in Chinese men and women. Indeed, we
observed that the effects of BP on CVD risk generally
increased with the increasing BMI levels.
In the present study, in baseline hypertensive partici-
pants obese men and women had the highest HRs of
Table 1: Baseline Characteristics and CVD Incidence Rates at Follow-Up According to Baseline BMI
Baseline characteristics Baseline BMI, kg/m2 P value for trend
<18.5 18.5-23.9 24-27.9 ≥ 28
No. of participants 16,543 79,220 33,401 10,404 --
Systolic BP (mean (SD), mm Hg) 121.8(22.8) 123.6(21.2) 130.5(21.8) 137.8(23.1) <0.0001
Diastolic BP (mean (SD), mm Hg) 72.5(11.7) 75.9(11.4) 80.9(11.7) 84.6(12.2) <0.0001
BMI (mean (SD), kg/m2) 17.2(1.1) 21.7(1.8) 26.9(1.3) 32.6(4.0) <0.0001
Person-years of follow-up 129,791 633,410 265,983 819,94 --
No. of CVD events 1,725 5,134 2,511 1046 --
Incidence of CVD, per 100,000 
Person-years
1329.06 810.53 944.05.19 1275.70 NA
Age (mean (SD), year) 60.1(11.5) 54.7(10.5) 54.4(9.8) 56.1(9.5) <0.0001
Men (%) 45.4 52.2 47.8 36.0 <0.0001
High school education (%) 11.1 21.0 32.9 28.6 <0.0001
Cigarette
smokers (%)
44.0 40.8 33.8 26.9 <0.0001
Alcohol consumption (%) 17.4 21.9 19.1 14.5 <0.0001
Physical
inactivity (%)
31.7 31.9 42.4 44.8 <0.0001
North (%) 41.3 60.8 77.1 85.0 <0.0001
Urban (%) 35.4 51.5 78.8 84.7 <0.0001
Hypertension(%) 20.2 21.8 35.0 49.9 <0.0001
Hypertension treatment(%) 0.9 1.5 3.9 7.0 <0.0001
SD, standard deviation; CVD, cardiovascular disease; BMI, body mass index; BP, blood pressure; NA: not applicable.Wang et al. BMC Public Health 2010, 10:189
http://www.biomedcentral.com/1471-2458/10/189
Page 5 of 7
CVD among 4 BMI levels (Figure 1). Our results did not
support that hypertension or high blood pressure was a
less serious risk factor for CVD in obese than in lean or
normal-weight persons in Chinese population.
It is very interesting that in baseline non-hypertensive
participants we found lean men and women had the high-
est HRsof CVD among 4 BMI levels (figure 2). An expla-
nation for these different findings between hypertensive
participants and non-hypertensive participants is the
change of total peripheral resistance during the patho-
logic process of hypertension. Raised total peripheral vas-
cular resistance is the hallmark of essential hypertension
and the major determinant of systemic hypertensive vas-
cular disease [28]. Arterial BP is determined by cardiac
output and total peripheral resistance. Any factor which
raises cardiac output or total peripheral resistance will
raise BP. Because obese persons are usually associated
with the augmented cardiac output (in response to ele-
vated metabolic requirements), at a given level of low or
normal BP, obese persons have low total peripheral resis-
tance while lean persons have high total peripheral resis-
tance which result in high risk of CVD. But it changed
Table 2: HRs on Risk of CVD for Relation of a 1-SD Increase in Systolic BP and Diastolic BP According to Baseline BMI
BMI Systolic BP Diastolic BP
HR* 95%CI HR* 95%CI
<18.5 kg/m2 1.27 1.21-1.33 1.25 1.19-1.31
18.5-23.9 kg/m2 1.45 1.41-1.48 1.42 1.38-1.46
24-27.9 kg/m2 1.52 1.45-1.59 1.49 1.41-1.56
≥ 28 kg/m2 1.63 1.51-1.76 1.53 1.41-1.65
All 1.42 1.40-1.45 1.40 1.37-1.43
P for interaction * <0.0001 <0.0001
HRs, hazard ratios; CI, confidence interval; CVD, cardiovascular disease; BMI, body mass index; BP, blood pressure.
*Adjusted for age, sex, cigarette smoking, alcohol consumption, high school education, physical inactivity, geographic region (south vs. 
north), and urbanization (rural vs. urban).
Table 3: HRs and 95%CI for the Relation of a 1-SD Increase in Systolic BP and Diastolic BP According to Baseline BMI 
Divided by Sex (men and women)
BMI Systolic BP Diastolic BP
HR* 95%CI HR* 95%CI
Men
<18.5 kg/m2 1.26 1.18-1.35 1.25 1.17-1.33
18.5-23.9 kg/m2 1.48 1.42-1.53 1.46 1.41-1.52
24-27.9 kg/m2 1.63 1.53-1.74 1.48 1.38-1.58
≥ 28 kg/m2 1.79 1.54-2.07 1.57 1.36-1.80
All 1.47 1.43-1.50 1.42 1.38-1.46
P for interaction* <0.0001 <0.0001
Women
<18.5 kg/m2 1.27 1.18-1.35 1.25 1.16-1.34
18.5-23.9 kg/m2 1.41 1.35-1.47 1.37 1.31-1.43
24-27.9 kg/m2 1.43 1.34-1.52 1.49 1.39-1.60
≥ 28 kg/m2 1.58 1.44-1.74 1.51 1.37-1.66
All 1.38 1.34-1.42 1.37 1.33-1.41
P for interaction* 0.0007 0.0008
HRs, hazard ratios; CI, confidence interval; CVD, cardiovascular disease; BMI, body mass index; BP, blood pressure.
*Adjusted for age, cigarette smoking, alcohol consumption, high school education, physical inactivity, geographic region and urbanization.Wang et al. BMC Public Health 2010, 10:189
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when BP increases continuously. As hypertension
becomes established, total peripheral resistance increases
and cardiac output reverts to normal [29]. Thus, at a
given level of high BP, total peripheral resistance is nearly
the same in an obese person comparing a lean or normal-
weight one. However, obese persons always were associ-
ated with other factors such as inflammation-sensitive
plasma proteins [30] which may induce excess risk of
CVD. As a consequence, at low or normal BP levels lean
persons have higher risk of CVD than normal-weight or
obese persons, but at high BP levels obese persons have
h i g h e r  r i s k  t h a n  l e a n  o r  n o r m a l - w e i g h t  p e r s o n s .  T h e
mechanism of combination effect of hypertension and
obesity needs further researches.
Our study has many advantages. It was conducted in a
large, nationally representative sample of the general
population, had a very high follow-up rate, and used
stringent quality control procedures in assessing baseline
variables and clinical study outcomes. In addition, the
study population had a relatively low average but corre-
spondingly wide range of BP levels. This allowed us to
examine the risk of CVD stratified by baseline BMI at a
lower level of BP. However, our study has potential limita-
tions as well. Some important risk factors for CVD, such
as serum lipids, diet, and leisure-time physical activity
were not measured and thus we cannot fully test whether
adjustment of the HRs for these risk factors would change
the interactive effect between BP and BMI. Variables
including HDL cholesterol, LDL cholesterol and blood
glucose would be possible confounders and adjustment
for these variables might reduce the predictive effect of
BMI on risk of CVD. However, major population-based
studies, including the Framingham heart study [31], the
Nurses' Health Study [32], and the US Male Health Pro-
fessionals Study [33], have demonstrated that BMI is still
an important risk factor for CHD incidence even after
adjustment for age, hypertension, diabetes, smoking sta-
tus, and cholesterol levels.
Conclusions
In the present large, nationally cohort study of Chinese
men and women, we found that there are significant
interactions between systolic BP, diastolic BP and BMI in
relation to CVD. The effects of BP on CVD risk generally
increased with the increasing BMI levels. Our results did
not supported that high blood pressure would be less
harmful in obese than in lean or normal-weight persons.
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